How to Get AndroGel in Rhode Island

At a glance
- Telehealth prescribing / legal in Rhode Island for AndroGel
- Compounding alternative / 503A pharmacies licensed to ship testosterone gel in RI
- RI Medicaid coverage / covered with prior authorization (PA) for male hypogonadism
- Standard dosing / once daily topical gel (1% or 1.62% formulation)
- Manufacturer / AbbVie (brand); generic testosterone gel also available
- Minimum labs before Rx / two morning total testosterone draws plus LH, FSH, and CBC
- Typical time to first dose / 3 to 10 days via telehealth; longer through insurance PA
- Who can prescribe / MD, DO, NP, and PA all hold prescribing authority in RI
What AndroGel Is and Why Diagnosis Must Come First
AndroGel is FDA-approved topical testosterone gel indicated exclusively for male hypogonadism, a condition defined by consistently low serum testosterone combined with clinical symptoms. The FDA label specifies that the diagnosis must be confirmed by laboratory testing before any prescription is written. [1] Symptoms alone are not sufficient for a legal prescription.
The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends measuring total testosterone on at least two separate morning occasions before starting any testosterone preparation. [2] "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs of androgen deficiency and unequivocally and repeatedly low serum testosterone concentrations," the guideline states directly. That single sentence defines the legal and clinical threshold every Rhode Island prescriber must clear.
Male hypogonadism affects roughly 2.1% of men aged 40 to 79 in population-based surveys, though rates climb steeply with age and comorbidities such as obesity and type 2 diabetes. [3] The T-Trials (N=788), published in the New England Journal of Medicine in 2016, remain the largest randomized, placebo-controlled dataset on testosterone treatment in older men with low testosterone and documented symptoms, showing statistically significant improvements in sexual function and bone density over 12 months. [4]
Getting the diagnosis right protects you legally, protects the prescriber, and ensures insurance coverage if you pursue it. Rhode Island Board of Medical Licensure and Discipline follows DEA Schedule III rules for testosterone, so every prescription must tie to documented clinical findings. [5]
Lab Work Required Before Any Rhode Island Provider Will Prescribe AndroGel
Most Rhode Island clinicians order a consistent core panel before writing an AndroGel prescription. Two morning total testosterone measurements are non-negotiable under Endocrine Society guidelines. [2] Labs must be drawn between 7 a.m. and 10 a.m. because testosterone follows a circadian rhythm and afternoon draws can underestimate true levels by 20 to 35%. [6]
A standard pre-treatment panel typically includes:
- Total testosterone (two separate mornings, ideally one week apart)
- Free testosterone or bioavailable testosterone (especially if SHBG abnormality is suspected)
- LH and FSH (to classify primary vs. secondary hypogonadism)
- Complete blood count (CBC) to establish baseline hematocrit
- PSA if age 40 or older
- Comprehensive metabolic panel (CMP)
- Estradiol (baseline, particularly useful for monitoring after gel initiation)
The FDA-approved AndroGel prescribing information requires hematocrit monitoring because supraphysiologic androgen levels can drive erythrocytosis, which raises cardiovascular risk. [1] Quest Diagnostics and LabCorp both maintain multiple draw sites across Providence, Cranston, Warwick, and Pawtucket. Many telehealth platforms active in Rhode Island now offer at-home blood collection kits or direct lab-order integration so patients never need a separate physician visit just for labs. [7]
The HealthRX clinical team applies a three-gate framework before approving any testosterone gel prescription through our platform: Gate 1 confirms two sub-300 ng/dL morning total testosterone results (or two results in the 300 to 400 ng/dL range with free testosterone below 65 pg/mL and moderate-to-severe symptom burden per the ADAM questionnaire). Gate 2 rules out secondary causes including hyperprolactinemia, pituitary pathology, and primary thyroid disease. Gate 3 screens for contraindications including prostate cancer history, untreated severe OSA, hematocrit above 50%, and active desire for fertility.
How Telehealth Works for AndroGel Prescriptions in Rhode Island
Rhode Island explicitly permits telehealth prescribing of controlled substances under state law, provided the prescriber holds an active Rhode Island medical license or an NP/PA with Rhode Island prescriptive authority, and the patient completes an appropriate medical evaluation. [8] A first-time testosterone prescription via telehealth must involve a synchronous audio-video encounter under current Rhode Island and DEA telehealth rules. Text-only or asynchronous-only initiation does not meet the standard.
The practical flow through a telehealth platform typically runs like this. First, you complete an online intake and upload or order labs. Second, a licensed Rhode Island provider reviews labs and conducts a live video consultation, usually 15 to 30 minutes. Third, the provider sends the prescription electronically to your chosen Rhode Island pharmacy or a mail-order pharmacy licensed to deliver into RI. Most platforms report a 3 to 7 business day window from initial intake to medication in hand, assuming labs are already completed. [9]
Several national TRT-focused telehealth companies hold Rhode Island provider licenses as of 2025. HealthRX operates in Rhode Island. Defy Medical, Fountain TRT, and Hims all list Rhode Island in their coverage maps. Each uses a different pricing model: some bill through insurance, others are direct-pay monthly subscriptions ranging from approximately $99 to $249 per month including medication.
Telehealth has expanded access meaningfully. A 2021 analysis in JAMA Internal Medicine found that testosterone prescribing through digital health platforms increased 52% between 2016 and 2020 across states with clear telehealth controlled-substance frameworks. [10] Rhode Island's regulatory posture puts it among the states where that growth is straightforward.
Finding an In-Person AndroGel Doctor in Rhode Island
Not every patient wants or can use telehealth. Rhode Island has endocrinologists and urologists in Providence at Rhode Island Hospital, Lifespan Medical, and Care New England who routinely manage hypogonadism. The Brown University Medical Group also has endocrine faculty who see testosterone-deficiency patients. [11]
Primary care physicians (PCPs) in Rhode Island can and do prescribe AndroGel, though practice patterns vary. Some PCPs are comfortable initiating and monitoring TRT; others prefer to co-manage with a specialist or refer outright. If your PCP declines, a direct referral to urology or endocrinology is a reasonable next step, and many RI urologists see new hypogonadism consults within two to four weeks.
The American Urological Association's 2018 testosterone deficiency guideline states that any licensed physician who can evaluate and diagnose the condition may prescribe testosterone therapy, with no mandatory specialist referral. [12] That means your PCP has the authority; the question is their individual comfort level.
AndroGel Dosing, Application, and Formulations Available in Rhode Island
AndroGel is available as a 1% formulation (delivering 50 mg testosterone per 5 g application) and a 1.62% formulation (delivering 20.25 mg or 40.5 mg per pump actuation). [1] The 1.62% version uses a metered pump and is the more commonly prescribed brand formulation today. Generic testosterone 1.62% gel entered the market after patent expiration and is widely stocked at Rhode Island retail pharmacies.
Standard starting doses per the FDA label are 40.5 mg (two pump actuations of 1.62%) applied once daily to the shoulders or upper arms. [1] Dose titration typically occurs at 14 days and again at 28 days based on morning serum testosterone drawn four to eight hours after application. The target range for most clinical protocols is 400 to 700 ng/dL, though some guidelines accept up to 750 ng/dL for symptomatic patients who remain sub-therapeutic at lower levels. [2]
Application site matters. AndroGel applied to the abdomen or inner thighs transfers readily to female partners and children, a serious safety concern documented in FDA postmarket surveillance. [1] The shoulders and upper arms are the approved sites because clothing covers them quickly. Patients must wash hands immediately after application and cover the site with clothing before any skin-to-skin contact.
Scrotal application is not approved for standard testosterone gel and should not be attempted with AndroGel. Compounded testosterone creams designed for scrotal application use different base formulations and carrier absorption profiles. [13]
Pharmacy Options: Retail, Mail-Order, and 503A Compounding in Rhode Island
Rhode Island residents have three practical pharmacy channels for AndroGel.
Retail pharmacies. CVS, Walgreens, Walmart Pharmacy, and independent pharmacies across the state stock brand-name AndroGel and generic testosterone 1.62% gel. Cash prices without insurance typically run $350 to $550 per month for brand AndroGel; generics drop that to $80 to $180 depending on the dispenser. GoodRx coupons can further reduce generic costs at RI chains. [14]
Mail-order pharmacies. Insurance-contracted mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) ship 90-day supplies at reduced copays for covered patients. Several telehealth-affiliated mail-order pharmacies ship into Rhode Island and handle the entire dispensing process without a local pharmacy visit.
503A compounding pharmacies. Rhode Island-licensed 503A compounding pharmacies can prepare patient-specific testosterone gel formulations upon a valid prescription. [15] Common compounded preparations include testosterone 10% cream and testosterone 2% gel in proprietary bases. Compounded testosterone is not FDA-approved and lacks the bioavailability data of the brand product, but costs are typically $40 to $100 per month cash-pay. The FDA distinguishes 503A pharmacies (patient-specific, prescription-required) from 503B outsourcing facilities (bulk production); Rhode Island compounders operating under 503A status may legally fill a physician's individualized prescription for testosterone gel. [15] The Pharmacy Compounding Accreditation Board (PCAB) maintains a searchable directory of accredited compounders, and patients should confirm any RI compounder holds active state Board of Pharmacy licensure.
Rhode Island Insurance Coverage and Prior Authorization for AndroGel
Rhode Island Medicaid (RIte Care and Medicaid fee-for-service) covers AndroGel for male hypogonadism with prior authorization. PA documentation requirements generally include two low morning testosterone lab results, documented symptoms, and the prescriber's attestation that the diagnosis meets criteria. [16] Approval timelines vary by plan: standard PA decisions must be returned within 72 hours under Rhode Island Medicaid rules, though peer-to-peer appeals can extend that window.
Commercial insurance in RI varies considerably. BCBSRI, Tufts Health Plan, and United Healthcare all list testosterone gel on formularies but typically at Tier 3 or Tier 4, which means higher copays. Most commercial plans require PA with documentation nearly identical to Medicaid requirements. Step therapy (trying a generic before the brand) is a common commercial plan requirement before brand AndroGel is approved. [17]
Medicare Part D covers testosterone gel under the same Schedule III rules as commercial plans, but coverage tier and PA requirements depend on the specific Part D plan. Patients on Medicare Advantage in Rhode Island should confirm formulary status with their specific plan before the prescription is sent.
If a PA is denied, Rhode Island law gives patients the right to an internal appeal and then an independent external review. For a medication with a documented laboratory diagnosis, first-level appeals succeed at a high rate when the clinical record is complete. [18]
Transferring an Existing AndroGel Prescription to Rhode Island
Moving to Rhode Island with an existing AndroGel prescription is straightforward in most cases. Federal law and Rhode Island pharmacy rules allow a pharmacist to transfer a valid Schedule III prescription once between pharmacies. [19] "Transfer once" means if the prescription was already transferred once in another state, Rhode Island law does not permit a second transfer. In that situation, you need a new prescription from a Rhode Island-licensed provider.
The simplest approach when relocating is a telehealth consultation with a RI-licensed provider who reviews your existing labs and clinical history. If testosterone levels and documentation are current (within 3 to 6 months), many providers will issue a new RI prescription at the initial visit without requiring repeat labs immediately, though most will order a fresh panel within 30 to 60 days. [9]
Patients who receive AndroGel through a specialty pharmacy in another state should confirm that pharmacy holds a Rhode Island non-resident pharmacy license through the RI Board of Pharmacy before expecting continued shipments. Most large mail-order pharmacies hold multi-state licenses, but confirmation is worth a five-minute phone call.
Monitoring After Starting AndroGel in Rhode Island
Starting AndroGel is not a set-and-forget intervention. The Endocrine Society recommends follow-up testosterone levels at 3 months and 12 months after initiation, with hematocrit checked at the same intervals. [2] PSA should be measured at 3 to 6 months and then annually in men over 40. [12]
The T-Trials found that testosterone-treated men had a mean increase in hematocrit of 3.6 percentage points versus 0.7 points for placebo over 12 months, underscoring why the CBC baseline and follow-up monitoring matter. [4] A hematocrit above 54% typically prompts dose reduction or temporary cessation. [2]
Testosterone gel transfers to skin-to-skin contacts. The FDA issued a black-box warning in 2009 specifically addressing secondary exposure in children. [1] Monitoring in partners and children living in the same household is warranted if any symptoms of virilization appear. [20]
Response assessment at 3 months should cover not just serum testosterone but patient-reported outcomes on symptom domains: libido, energy, mood, and morning erections. The International Index of Erectile Function (IIEF) is a validated tool many RI providers use at baseline and follow-up to track response quantitatively. [21]
Cost-Reduction Strategies for AndroGel in Rhode Island
AbbVie maintains a patient assistance program for brand AndroGel for patients who meet income criteria, accessible directly through AbbVie's myAbbVie Assist program. [22] Generic testosterone 1.62% gel paired with a GoodRx or RxSaver coupon at a Rhode Island Walmart Pharmacy or Costco Pharmacy consistently delivers the lowest cash prices, often below $70 per month for the standard 2-pump-per-day dose. [14]
Telehealth subscription platforms that bundle the provider visit fee, labs, and medication into a single monthly cost can reduce total out-of-pocket spending for uninsured or high-deductible patients compared to a la carte in-person care. The break-even point depends on your specific insurance situation, but for patients with no coverage or high-deductible plans, all-in telehealth costs of $120 to $180 per month including generic medication typically beat the sum of a specialist co-pay plus pharmacy cost. [9]
Frequently asked questions
›How do I get an AndroGel prescription in Rhode Island?
›What labs are needed before AndroGel in Rhode Island?
›Are there telehealth providers in Rhode Island prescribing AndroGel?
›How long until I receive AndroGel in Rhode Island?
›Can I transfer an AndroGel prescription to Rhode Island?
›Are 503A pharmacies in Rhode Island licensed to ship testosterone gel?
›Who can prescribe AndroGel in Rhode Island, MD vs NP vs PA?
›What documentation does prior authorization require in Rhode Island?
References
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1.62% prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022504s022lbl.pdf
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men. J Clin Endocrinol Metab. 2004;89(12):5920-5926. https://pubmed.ncbi.nlm.nih.gov/15579737/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Drug Enforcement Administration. Practitioner's manual: controlled substances scheduling. https://www.deadiversion.usdoj.gov/pubs/manuals/pract/section4.htm
- Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94(3):907-913. https://pubmed.ncbi.nlm.nih.gov/19088162/
- American Urological Association. Hormone testing resources for testosterone deficiency management. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Rhode Island Department of Health. Telemedicine and telehealth: prescribing rules for controlled substances. https://health.ri.gov/licenses/detail.php?id=232
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Jaspers L, Dhana K, Muka T, et al. Sex hormones and functional health in older adults: a systematic review. Eur J Epidemiol. 2015;30(10):1073-1083. https://pubmed.ncbi.nlm.nih.gov/26231283/
- National Institutes of Health. Testosterone and men's health: endocrine overview. MedlinePlus. https://medlineplus.gov/testosterone.html
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline amendment 2022. https://pubmed.ncbi.nlm.nih.gov/35094822/
- U.S. Food and Drug Administration. Compounded drug products that are essentially a copy of a commercially available drug product. Guidance for industry. https://www.fda.gov/media/124698/download
- Centers for Medicare and Medicaid Services. Drug price transparency resources. https://www.cms.gov/medicare/prescription-drug-coverage
- U.S. Food and Drug Administration. Compounding: 503A pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-pharmacies
- Rhode Island Executive Office of Health and Human Services. Rhode Island Medicaid pharmacy prior authorization clinical criteria. https://www.medicaid.gov/state-overviews/stateprofile.html?state=rhode-island
- America's Health Insurance Plans. Step therapy utilization in commercial insurance: 2023 survey findings. https://www.ahip.org/resources/step-therapy
- Rhode Island Office of the Health Insurance Commissioner. External review of insurance decisions: patient rights. https://ohic.ri.gov/consumer-services
- U.S. Drug Enforcement Administration. Pharmacist's manual: transfer of prescriptions for schedule III-V substances. https://www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_manual.htm
- U.S. Food and Drug Administration. FDA drug safety communication: testosterone products secondary exposure risk. 2009. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-pulmonary-oil-microembolism-reactions-after
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830. https://pubmed.ncbi.nlm.nih.gov/9187685/
- AbbVie patient assistance program: myAbbVie Assist. https://www.rxassist.org/patients/resource-detail/6217